Wunderer G, Walter I, Müller E, Henschen A
Biol Chem Hoppe Seyler. 1986 Dec;367(12):1231-4. doi: 10.1515/bchm3.1986.367.2.1231.
Ascites from patients with metastatic ovarian carcinoma contains high amounts of an activity that increases vascular permeability, as easily detected by a rat skin test. Ascites was fractionated by gel permeation and reversed-phase high-performance liquid chromatographies. The fractions were analysed for permeability-increasing activity. In this way a peptide was isolated and identified as Ile-Ser-bradykinin by sequence and amino-acid analyses. It is identical with T-kinin which has previously been detected as a product of an acute-phase protein, T-kininogen, in rats but never in human material. The so far identified human kininogens, i.e. high- and low-molecular mass kininogens, can only release Met-Lys-bradykinin or its degradations products, as Ile-Ser-bradykinin is not a part of their structure. However, the present results provide evidence that the permeability factor Ile-Ser-bradykinin under certain conditions can be produced in considerable amounts also by human tissues.
转移性卵巢癌患者的腹水中含有大量可增加血管通透性的活性物质,通过大鼠皮肤试验可轻易检测到。腹水通过凝胶渗透和反相高效液相色谱进行分级分离。对各馏分进行增加通透性活性分析。通过这种方式分离出一种肽,并通过序列和氨基酸分析鉴定为异亮氨酸 - 丝氨酸 - 缓激肽。它与T - 激肽相同,T - 激肽先前在大鼠中被检测为急性期蛋白T - 激肽原的产物,但从未在人类材料中检测到。迄今为止已鉴定的人类激肽原,即高分子量和低分子量激肽原,只能释放甲硫氨酸 - 赖氨酸 - 缓激肽或其降解产物,因为异亮氨酸 - 丝氨酸 - 缓激肽不是它们结构的一部分。然而,目前的结果提供了证据,表明在某些条件下,人类组织也可以大量产生通透性因子异亮氨酸 - 丝氨酸 - 缓激肽。